Non-redundant Functions of Cyclooxygenases: Oxygenation of Endocannabinoids*
暂无分享,去创建一个
[1] L. Mestre,et al. Anandamide inhibits IL-12p40 production by acting on the promoter repressor element GA-12: possible involvement of the COX-2 metabolite prostamide E(2). , 2008, The Biochemical journal.
[2] Nigel Mackman,et al. COX-2 suppresses tissue factor expression via endocannabinoid-directed PPARδ activation , 2007, The Journal of experimental medicine.
[3] N. Sang,et al. COX‐2 oxidative metabolite of endocannabinoid 2‐AG enhances excitatory glutamatergic synaptic transmission and induces neurotoxicity , 2007, Journal of neurochemistry.
[4] L. Marnett,et al. Lipid profiling reveals glycerophospholipid remodeling in zymosan-stimulated macrophages. , 2007, Biochemistry.
[5] G. FitzGerald,et al. Targeted Cyclooxygenase Gene (Ptgs) Exchange Reveals Discriminant Isoform Functionality* , 2007, Journal of Biological Chemistry.
[6] L. Marnett,et al. Lipid profiling reveals arachidonate deficiency in RAW264.7 cells: Structural and functional implications. , 2006, Biochemistry.
[7] William L. Smith,et al. The 19-amino Acid Cassette of Cyclooxygenase-2 Mediates Entry of the Protein into the Endoplasmic Reticulum-associated Degradation System* , 2006, Journal of Biological Chemistry.
[8] L. Marnett,et al. Zymosan-induced glycerylprostaglandin and prostaglandin synthesis in resident peritoneal macrophages: roles of cyclo-oxygenase-1 and -2. , 2006, The Biochemical journal.
[9] A. Saghatelian,et al. A FAAH-regulated class of N-acyl taurines that activates TRP ion channels. , 2006, Biochemistry.
[10] N. Sang,et al. PGE2 glycerol ester, a COX‐2 oxidative metabolite of 2‐arachidonoyl glycerol, modulates inhibitory synaptic transmission in mouse hippocampal neurons , 2006, The Journal of physiology.
[11] H. Yin,et al. Convergent oxygenation of arachidonic acid by 5-lipoxygenase and cyclooxygenase-2. , 2006, Journal of the American Chemical Society.
[12] Garret A FitzGerald,et al. Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities. , 2005, The Journal of clinical investigation.
[13] Lawrence J Marnett,et al. Glycerylprostaglandin Synthesis by Resident Peritoneal Macrophages in Response to a Zymosan Stimulus* , 2005, Journal of Biological Chemistry.
[14] C. Lines,et al. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. , 2005, The New England journal of medicine.
[15] R. Breyer,et al. Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation. , 2004, Pharmacology & therapeutics.
[16] B. Alger,et al. Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus , 2004, Nature Neuroscience.
[17] B. Cravatt,et al. Formation of prostamides from anandamide in FAAH knockout mice analyzed by HPLC with tandem mass spectrometry Published, JLR Papers in Press, January 16, 2004. DOI 10.1194/jlr.M300475-JLR200 , 2004, Journal of Lipid Research.
[18] D. Woodward,et al. Update on the mechanism of action of bimatoprost: a review and discussion of new evidence. , 2004, Survey of ophthalmology.
[19] J. Morrow,et al. The glyceryl ester of prostaglandin E2 mobilizes calcium and activates signal transduction in RAW264.7 cells , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[20] L. Marnett,et al. Amino acid determinants in cyclooxygenase-2 oxygenation of the endocannabinoid anandamide. , 2003, Biochemistry.
[21] Lawrence J Marnett,et al. Mechanism of free radical oxygenation of polyunsaturated fatty acids by cyclooxygenases. , 2003, Chemical reviews.
[22] W. A. van der Donk,et al. The cyclooxygenase reaction mechanism. , 2002, Biochemistry.
[23] J. Morrow,et al. Metabolism of the Endocannabinoids, 2-Arachidonylglycerol and Anandamide, into Prostaglandin, Thromboxane, and Prostacyclin Glycerol Esters and Ethanolamides* , 2002, The Journal of Biological Chemistry.
[24] L. Marnett,et al. Selective oxygenation of N-arachidonylglycine by cyclooxygenase-2. , 2002, Biochemical and biophysical research communications.
[25] J. Morrow,et al. Metabolism of Prostaglandin Glycerol Esters and Prostaglandin Ethanolamides in Vitro and in Vivo * , 2001, The Journal of Biological Chemistry.
[26] L. Marnett,et al. Amino Acid Determinants in Cyclooxygenase-2 Oxygenation of the Endocannabinoid 2-Arachidonylglycerol* , 2001, The Journal of Biological Chemistry.
[27] R. Langenbach,et al. Why there are two cyclooxygenase isozymes. , 2001, The Journal of clinical investigation.
[28] L. Marnett,et al. Oxygenation of the Endocannabinoid, 2-Arachidonylglycerol, to Glyceryl Prostaglandins by Cyclooxygenase-2* , 2000, The Journal of Biological Chemistry.
[29] C. Ramesha,et al. Synthesis of Prostaglandin E2 Ethanolamide from Anandamide by Cyclooxygenase-2* , 1997, The Journal of Biological Chemistry.
[30] D. Piomelli,et al. A second endogenous cannabinoid that modulates long-term potentiation , 1997, Nature.
[31] L. Petrocellis,et al. Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-arachidonoylglycerol in mouse neuroblastoma cells. , 1997, The Biochemical journal.
[32] J. Chow,et al. Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2 , 1996, Nature Structural Biology.
[33] P. Worley,et al. COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[34] Lee-Ho Wang,et al. Comparison of Hydroperoxide Initiator Requirements for the Cyclooxygenase Activities of Prostaglandin H Synthase-1 and −2 (*) , 1995, The Journal of Biological Chemistry.
[35] William L. Smith,et al. Fatty Acid Substrate Specificities of Human Prostaglandin-endoperoxide H Synthase-1 and −2 , 1995, The Journal of Biological Chemistry.
[36] J. Otto,et al. Localization of prostaglandin endoperoxide synthase-1 to the endoplasmic reticulum and nuclear envelope is independent of its C-terminal tetrapeptide-PTEL. , 1995, Archives of biochemistry and biophysics.
[37] H. Jacobson,et al. Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction. , 1994, The Journal of clinical investigation.
[38] K. Seibert,et al. Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[39] P. Loll,et al. The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1 , 1994, Nature.
[40] M. Schindler,et al. Subcellular localization of prostaglandin endoperoxide synthase-2 in murine 3T3 cells. , 1993, Archives of biochemistry and biophysics.
[41] V. Winn,et al. cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[42] B. Varnum,et al. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. , 1991, The Journal of biological chemistry.
[43] R. Erikson,et al. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[44] D. Dewitt,et al. Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined from the complementary DNA sequence. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[45] R. Gorman,et al. The inhibition of arachidonic acid metabolism in human platelets by RHC 80267, a diacylglycerol lipase inhibitor. , 1984, Biochimica et biophysica acta.
[46] S. Yamamoto,et al. Purification of prostaglandin endoperoxide synthetase from bovine vesicular gland microsomes. , 1976, The Journal of biological chemistry.
[47] J. Vane,et al. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. , 1971, Nature: New biology.
[48] B. Samuelsson,et al. THE ENZYMATIC FORMATION OF PROSTAGLANDIN E2 FROM ARACHIDONIC ACID PROSTAGLANDINS AND RELATED FACTORS 32. , 1964, Biochimica et biophysica acta.
[49] L. Petrocellis,et al. The biosynthesis, fate and pharmacological properties of endocannabinoids. , 2005, Handbook of experimental pharmacology.
[50] L. Marnett,et al. COX-2: a target for colon cancer prevention. , 2002, Annual review of pharmacology and toxicology.
[51] R. Garavito,et al. Cyclooxygenases: structural, cellular, and molecular biology. , 2000, Annual review of biochemistry.
[52] R. Kurumbail,et al. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents , 1996, Nature.
[53] H. Ruf,et al. Higher oxidation states of prostaglandin H synthase , 1988 .